Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Is the UK’s drug evaluation system in need of an overhaul?

A recent parliamentary debate surrounding access to Orkambi, a new treatment for cystic fibrosis, elicited some scathing remarks about NICE, the medical board responsible for introducing new drugs in the UK. So, is this approval process, developed nearly 20 years ago, no longer up to scratch?


Go Top